Take Your Trading To The Next Level. Get Started Here!

Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial

June 20, 2024 Comments Off

Gilead’s experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.